Alberto M. L.
- Country
- Spain
- Department
- Internal Medicine
Research Overview
Data & Insights
Has run more than one trial at 3 of 60 partner sites.
Specializations
Pancreatic Cancer Research
The investigator specializes in treating metastatic pancreatic adenocarcinoma, with particular emphasis on novel therapeutic approaches for patients with liver metastases. Their research encompasses innovative treatment strategies for advanced-stage pancreatic cancer.
- Advanced Pancreatic Cancer Treatment
- Metastatic Disease Management
- First-line Treatment Protocols
A key focus is the exploration of combination therapies involving tumor treating fields and established chemotherapy regimens.
Novel Therapeutic Approaches
The investigator is involved in evaluating innovative treatment combinations for pancreatic ductal adenocarcinoma. Their work includes the assessment of new therapeutic agents in conjunction with standard treatment protocols.
- Combination Therapy Development
- Treatment Enhancement Strategies
- Survival Outcome Studies
Research activities center on investigating the efficacy of novel compounds like SBP-101 in combination with established chemotherapeutic agents.
Clinical Treatment Optimization
The investigator focuses on optimizing treatment protocols for advanced pancreatic cancer, particularly in the first-line treatment setting. Their work involves evaluating the safety and effectiveness of various therapeutic combinations.
- Treatment Protocol Development
- Safety Profile Assessment
- Therapeutic Response Evaluation
Special attention is given to developing treatments for patients with previously untreated metastatic disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.